Understanding Insulin Resistance: A Systemic Health Issue

Insulin Resistance: A Whole-Body Disorder

Insulin resistance is a significant health concern that extends beyond elevated blood sugar levels. It is a complex pathophysiological condition that disrupts various bodily systems, including reproductive hormones, vascular health, inflammation, and sexual function. Understanding insulin resistance helps explain why seemingly unrelated conditions, such as polycystic ovary syndrome (PCOS) (now also known as PMOS — Polyendocrine Metabolic Ovarian Syndrome) and erectile dysfunction, share a common metabolic basis.

Understanding Insulin Resistance

At its core, insulin resistance occurs when the body's cells, particularly in the skeletal muscle, liver, and adipose tissue, fail to respond effectively to insulin. This impaired signalling through the insulin receptor leads to a reduced activation of the PI3K/Akt pathway, which is crucial for glucose uptake and glycogen synthesis.

As a compensatory response, the pancreas produces more insulin, resulting in hyperinsulinaemia. Over time, elevated insulin levels disrupt lipid metabolism, increase androgen production, contribute to vascular dysfunction, and promote inflammation.

This inflammatory state is perpetuated by adipocytes, which release pro-inflammatory cytokines like TNF-α, IL-6, and resistin. These factors lead to further reductions in insulin receptor sensitivity. This vicious cycle underscores the systemic impact of insulin resistance, making it a critical focus in weight management and metabolic health.

Insulin Resistance and Female Hormones

In women, hyperinsulinaemia can significantly influence reproductive health. Elevated insulin levels stimulate ovarian theca cells, resulting in increased androgen production. High androgen levels can disrupt folliculogenesis, leading to anovulation and menstrual irregularities.

Additionally, excess insulin decreases the hepatic production of sex hormone-binding globulin (SHBG), resulting in higher levels of free testosterone in circulation. Clinically, women may experience symptoms such as acne, hirsutism, and infertility, often linked to weight fluctuations.

Inflammation and Immune Response

Insulin resistance is intrinsically linked to chronic inflammation, which exacerbates several health issues. The infiltration of macrophages into adipose tissue releases inflammatory cytokines, worsening vascular health and accelerating the progression of atherosclerosis. Patients with metabolic syndrome often exhibit elevated levels of C-reactive protein (CRP) and other markers of systemic inflammation, indicating a heightened risk for cardiovascular diseases.

Male Sexual Health and Erectile Dysfunction

Healthy erectile function relies on the production of endothelial nitric oxide (NO), which facilitates smooth muscle relaxation. However, insulin resistance diminishes endothelial NO synthase activity and increases oxidative stress, leading to impaired vasodilation.

As a result, men with insulin resistance may experience erectile dysfunction even before developing overt diabetes. This condition is increasingly recognised as an early indicator of cardiometabolic disease in men.

Libido and Sexual Function in Women

Insulin resistance can disrupt the balance of hormones, including oestrogen and progesterone, while driving androgen excess. This hormonal imbalance often results in decreased libido, vaginal dryness, and discomfort during intercourse. Psychological factors, such as fatigue and mood disturbances, further complicate sexual health issues, impacting overall quality of life.

Other Hormonal Interactions

Insulin resistance also interacts with other hormonal axes:

Cortisol: Chronic stress combined with hyperinsulinaemia can lead to increased abdominal fat.
Thyroid: Insulin resistance may impair the conversion of T4 to T3, leading to subclinical hypothyroid states.
Appetite hormones: Dysregulation of leptin and ghrelin can increase hunger and decrease satiety, perpetuating weight gain and further exacerbating insulin resistance.

The Bigger Picture

Insulin resistance is more than just a problem related to sugar metabolism; it is a systemic endocrine and inflammatory disorder. If left unmanaged, it raises the risk for not only type 2 diabetes but also infertility, sexual dysfunction, cardiovascular disease, and a reduced quality of life.

Early intervention through lifestyle changes, weight management, and, when necessary, pharmacotherapy can reverse many of these changes, preventing irreversible damage and enhancing overall health.

In my clinical practice at Downscale Health, I emphasise the importance of a holistic approach to managing insulin resistance. By addressing weight, lifestyle, and hormonal balance, we can significantly improve health outcomes for individuals affected by this condition.

References

Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J (eds). Harrison’s Principles of Internal Medicine, 21st Edition. McGraw-Hill Education; 2022.
Kumar V, Abbas AK, Aster JC. Robbins & Cotran Pathologic Basis of Disease, 10th Edition. Elsevier; 2021.
Melmed S, Auchus RJ, Goldfine AB, Koenig RJ, Rosen CJ (eds). Williams Textbook of Endocrinology, 15th Edition. Elsevier; 2025.
Legro RS, Arslanian SA, Ehrmann DA, et al. “Diagnosis and treatment of polycystic ovary syndrome (now also known as PMOS — Polyendocrine Metabolic Ovarian Syndrome): An Endocrine Society clinical practice guideline.” J Clin Endocrinol Metab. 2023;108(4):1073-1097.
Samuel VT, Shulman GI. “The pathogenesis of insulin resistance: integrating signalling pathways and substrate flux.” Nat Rev Endocrinol. 2023;19(4):231-248.
Eckel RH, Kahn SE, Ferrannini E, Goldfine AB, Nathan DM, Schwartz MW, et al. “Obesity and type 2 diabetes: pathophysiology and new therapeutics.” Lancet. 2023;401(10380):2239-2252.
Esposito K, Maiorino MI, Bellastella G, Giugliano D. “Insulin resistance and erectile dysfunction: an update.” Nat Rev Urol. 2022;19(6):351-366.